Browse by popular tags
abvd ac220 act acute lymphoblastic leukaemia acute myelogenous leukemia (aml) acute myeloid leukaemia ade admire adoptive cellular therapy alemtuzumab all allogeneic allogeneic stem cell transplant amgen aml aml 17 aml 18 pilot angioimmunoblastic lymphoma antiviral therapy arctic aspirin autologous stem cell transplant autologous transplant azacitidine b-cell b-cell chronic lymphocytic leukaemia blood cancers bone marrow bortezomib
NHS Logo
The Clinical research facility is part of the NIHR and is funded by the Department of Health
The AML 17 trial has two distinct parts:
i.For patients with acute myeloid leukaemia (AML), (other than acute promyelocytic leukaemia) and High Risk Myelodysplasia, as defined by the WHO Classification (2001) (Appendix A, protocol).
ii.For adults with acute promyelocytic leukaemia (APL).